Abstract
INTRODUCTION
Maytenus erythroxylon Reissek (Celastraceae), popu larly known as "bom nome" [1] and "cascagrossa", is a small shrubby tree, measuring about 3.8 m high [2] and used traditionally to treat diseases of the gastrointestinal tract. Studies with Maytenus genus have presented promising results for treatment of gastrointestinal disorders, like peptic ulcers [37] and diarrhea [6, 8] . Besides, a lot of Maytenus species possess popular indication for treatment of diarrhea, such as M. rigida Mart [6] . and M. senegalensis Lam. Exell [9] . Most of their biological activities are attributed to the presence of phenolic compounds, particularly flavonoids, tannins, glyco sides, terpenes, steroids and alkaloids [10] , which have already been referenced in pharmacologic studies as antidiarrheal agents [1114] . Diarrhea is a debilitating gastrointestinal con dition [15] that involves an increase of unformed stools and also of the defecation frequency (three times or more in a day) [16] . The etiology of diarrheal disorders is multifactorial, attributed to factors such as infectious agents, microorganisms and their toxins, increased fluid secretion, malabsorption of biliary salts [17] , food allergies [18] and some medications, like antibiotics [19] . Diarrhea is responsible for up to 5 million deaths each year [20] , especially of children of less than 5
years, corresponding to 500000 deaths annually in developing countries [21] and associated with factors such as poor home environments, undernutrition and lack of access to essential services [22] . Available drugs used in diarrhea pharmacotherapy are related to contraindications and undesirable effects, like bronchospasm, vomiting and fever [16] . In this context, the World Health Organization (WHO) created a Diarrheal Disease Control Program that stimulates studies with natural products, especially traditional medicinal plants, for the management of diarrhea worldwide [23] . From this perspective, the present study aimed to present the phytochemical profile, acute toxicity, antidiarrheal activity and mechanisms of action of the ethanol extract obtained from the aerial parts from Maytenus erythroxylon (EtOHEMe).
MATERIALS AND METHODS

Reagents
The drugs and reagents were prepared immediately before use. The following drugs were used: carboxy methylcellulose (Formula Brasil 
Plant materials
Phytochemical screening of EtOHE-Me
EtOHEMe was subjected to preliminary phytochemical screening [24] for the detection of the presence of various phytoconstituents (alkaloids, saponins, steroids, triterpenoids, flavonoids and tannins). Alkaloids were detected using the Dragendorff's reagent, resulting in the appearance of a precipitate at the bottom of the test tube. Flavonoids were considered present when a yellow color appeared upon AlCl3 reagent addition and tannins when a green or black color was produced with FeCl3. For the detection of sterols and triterpenes, petroleum ether was used and extracted with CHCl3. Sterols were detected when a green to pink color appeared and pink to purple color for terpenes, following treatment of the CHCl3 layer with acetic anhydride and concentrated HCl. Saponins were detected when persistent froth appeared after vigorous shaking of diluted samples. The metabolic fingerprinting assessment of EtOHEMe was also performed by 1 Hnuclear magnetic resonance (NMR) and 13 
Toxicological evaluation
Investigation of the acute toxicity of EtOHE-Me in mice: The toxicological research was conducted in order to assess behavioral parameters and to determine LD50, according to the model described by Almeida et al [25] and Anvisa [26] . Male and female mice (n = 7) were fasted for 12 h and treated with EtOHE Me orally in a single dose (2000 mg/kg, solubilized in saline solution 0.9%) for two groups (male and female mice). Simultaneously, two other groups (male and female) were treated with NaCl 0.9% (10 mL/kg). Then, a behavioral screening was carried out and signs and symptoms of acute toxicity were observed and noted for 72 h. For 14 d, the animals were evaluated with respect to water and food consumption and body weight gain, and to observe if there were deaths. At the end of the experiment, the animals were euthanized for macroscopic analysis of organs (heart, spleen, liver and kidneys).
Pharmacological assays
Effect of EtOHE-Me on castor oil-induced diarrhea in mice: The antidiarrheal activity was evaluated according to the model described by Awouters et al [27] . Male mice were divided into six groups (n = 7) and pretreated orally with NaCl 0.9% (10 mL/kg), loperamide 5 mg/kg and EtOHEMe (62.5, 125, 250 and 500 mg/kg). After 1 h, 10 mL/kg of castor oil was administered orally to each animal in order to induce diarrhea. Feces were counted for 4 h and classified according to their consistency in solids, semisolids or liquids. Then, the Evacuation Index (EI), Percentual of Wet feces (%) and Diarrheal Inhibition (%) were calculated. EI = ∑ (solid stools × 1) + (semisolid stools × 2) + (liquid 3 × 3)
% DI = (Mean of saline group mean of treated group)/Mean of saline group × 100
Effects of EtOHE-Me on gastric emptying: Altera tions in gastric emptying were assessed according to the model described by Scarpignato et al [28] . After 1 h of pretreatment as described above, 0.4 mL of semisolid colored marker (phenol red 0.05% in 1.5% carboxymethylcellulose) was administered to the non treated control group (the zerotime control group) and the mice were euthanized immediately. The treated groups received this marker and euthanized 30 min after administration. The abdominal cavity was opened for stomach removal, with necessity of ligation of the pyloric and lower esophageal sphincters to avoid loss of the stomach contents. The gastric content was collected in Falcon ® tubes, solubilized in 7 mL of distilled water and centrifuged at 3000 rpm for 15 min. Then, 1 mL of the supernatant was mixed with 1 mL of 0.025 N NaOH and stirred using a vortex. From this material, 150 µL were pipetted into duplicate microplates and the spectrophotometric reading was made for wavelength equal to 570 nm. The results were expressed as percentage of induced enteropooling model. The animals were fasted for 24 h and treated orally with NaCl 0.9% (10 mL/kg), loperamide 5 mg/kg and EtOHEMe at its best dose (500 mg/kg). After 1 h, 10 mL/kg of castor oil was administered to animals orally. Then, 1 h later, the animals were euthanized for removal of the small intestine, after which the intestinal content was measured with the aid of a graduated cylinder.
Ethical consideration
All protocols performed in the present study were in accordance with international principles for research with laboratory animals [32] .
Animal care and use statement
All experimental procedures were approved by the Institutional Committee for Ethics in Animal Use from UFPB (No. 0105/14).
Statistical analysis
Parametric data were expressed as mean ± SD and nonparametric data as median (minimummaximum values). The data were subjected to ttest to compare two groups (control and treated group) and variance analysis (oneway ANOVA) to compare more than two groups, followed by a Dunnett and Tukey test (parametric) or KruskalWallis followed by Dunn test (nonparametric). P < 0.05 was considered as statistically significant. GraphPad Software © 5.0 (United States) was used for data processing.
RESULTS
Phytochemical screening of EtOHE-Me
In the present study, the results demonstrated the presence of saponins, flavonoids, tannins, steroids and triterpenes in EtOHEMe ( gastric emptying in relation to the control (zerotime group). % gastric emptying = (100 mean absorbance of sample)/Mean absorbance of zerotime control group × 100
Effects of EtOHE-Me on normal intestinal transit:
Alterations in normal intestinal transit were evaluated according to the model described by Stickney and Northup [29] . After 60 min of the pretreatment, 10 mL/kg (p.o.) Black marker (5% charcoal suspension in 5% Arabic gum) was administered. After 30 min, the animals were euthanized for removal of the small intestine (pylorus to the ileocecal junction). Using a ruler, the total length of the small intestine and the distance traveled by the black marker (last portion comprising at least one continuous score) were measured to calculate the percentage of the charcoal meal route depending on the total length of the intestine. % intestinal transit = length traveled by charcoal meal/Total intestinal length × 100
Antimotility mechanisms of action of EtOHE-Me
The antimotility mechanisms of action were evaluated according to the model described by Santos and Rao [30] . Male mice were fasted for 24 h and subsequently treated orally with NaCl 0.9% (10 mL/kg) and EtOHE Me at its best dose (500 mg/kg). To obtain information about the mechanism of action, different drugs acting via a wellknown mechanism were administered either alone and in association with EtOHEMe, such as glibenclamide (1 mg/kg i.p.), a blocker of KATP channels, LNAME (1 mg/kg i.p.), an inhibitor of nitric oxide synthase (NOs), propranolol (1 mg/kg i.p.), a nonselective adrenergic antagonist, and yohimbine (1 mg/kg i.p.), a presynaptic α2adrenergic antagonist. These drugs were dissolved in NaCl 0.9% and given 30 min before extract administration. After 60 min, 10 mL/kg (p.o.) of the black marker (5% charcoal suspension in 5% Arabic gum) was administered and 30 min later, the animals were euthanized for removal of the small intestine to calculate the percentage of intestinal transit.
Antisecretory mechanisms of action of EtOHE-Me
The antisecretory mechanism of action was evaluated according to Ezeja and Anaga [31] using the castor oil 
Investigation of the acute toxicity of EtOHE-Me in mice
The results showed low toxicity after the singledose administration (2000 mg/kg) of EtOHEMe, evidenced by lack of death during 14 d of the experiment and no apparent behavioral changes. Furthermore, there were no changes in body weight (Table 2) or organ weights of treated animals (Table 3) , and no changes in the consumption of water and food, when compared to the group treated only with NaCl 0.9% (Table 4) .
Effect of EtOHE-Me on castor oil-induced diarrhea in mice
In the present study, mice in the control group treated only with vehicle (NaCl 0.9%) showed intense signs of diarrhea, with respective evacuation index of 21 (1925) and 47% wet feces. Pretreatment with EtOHE Me at all doses (62.5, 125, 250 and 500 mg/kg) decreased the evacuation index of 8 (511) with 62% showing diarrhea inhibition (P < 0.05), 7 (68) showing 66% (P < 0.05), 6.5 (37) showing 69% (P < 0.05) and 4 (35) showing 80% (P < 0.001) respectively, when compared with the NaCl 0.9% control group. The standard antidiarrheal drug loperamide (5 mg/kg) produced a significant inhibition of all parameters evaluated ( Table 5) .
Effects of EtOHE-Me on gastric emptying of mice
The animals treated with NaCl 0.9% showed 79% of gastric emptying and and the treatment with EtOHEMe (125, 250 or 500 mg/kg) and loperamide significantly reduced gastric emptying in 66% (P < 0.05), 45% (P < 0.001), 47% (P < 0.001) and 53% (P < 0.001) respectively, when compared to the NaCl 0.9% control group (Figure 1 ).
Effects of EtOHE-Me on intestinal transit of mice
The distance travelled by charcoal in terms of percent of the total length of intestine was 76% in the NaCl 0.9% control group. The treatment with loperamide and EtOHEMe in all doses produced significant (P < 0.001) reduction in the percentage of intestinal transit in 25%, 57%, 49%, 41% and 35% respectively, when compared to the control group (Figure 2 ).
Antimotility mechanisms of action of EtOHE-Me
The distance travelled by charcoal meal was 78% in the NaCl 0.9% control group. The treatment with EtOHEMe at its best dose (500 mg/kg) produced significant (P < 0.001) reduction in the percentage of intestinal transit (36%), when compared to the NaCl 0.9% group. Although, when EtOHEMe was associated with the standard drugs LNAME, glibenclamide and propranolol, an increase in the intestinal transit was observed to 78%, 70% and 74% respectively. The same effect was not reproduced when EtOHEMe was administrated along with yohimbine (36% of intestinal transit) (Figure 3 ).
Antisecretory mechanisms of action of EtOHE-Me
EtOHEMe at its best dose (500 mg/kg) reduced intestinal fluid (0.6429 ± 0.1272), with 51% of fluid inhibition (P < 0.001), when compared to the NaCl 0.9% control group (1.325 ± 0.2053) (Figure 4 ).
DISCUSSION
Phytochemical screening showed the presence of saponins, flavonoids, tannins, triterpenes and steroids in EtOHEMe. Therefore, the absence of signals in the aromatic region along with the previous isolated fridelane terpene from Maytenus erythroxylon, 3βfriedelinol [33] corroborate that the signals presented in the 1 H and 13 C NMR spectra of the extract sample evaluated are from terpenes. The compounds found in the extract are mostly liked to increase water and electrolyte absorption in the colon, decrease intestinal irritability, and reduce intestinal propulsion and spasmolitic effect [1114] . Considering those findings, they might be responsible for the biological activities evidenced in the present study.
The studies of acute toxicity are important to determine the LD50 and set doses to be used in later experimental models [26] . The singledose administration of EtOHEMe did not alter any parameter evaluated and showed no deaths, with LD50 considered over 2000 mg/kg (p.o.) and the extract considered safe for pharmacological studies.
Then, it was investigated whether Maytenus ery throxylon ethanol extract possessed antidiarrheal effect. For that, the castor oilinduced diarrhea model in mice was used. Castor oil is a potent laxative agent and induces diarrhea through its active compound, the ricinoleic acid [34] , which acts in the upper small intestine where castor oil is hydrolyzed. It produces cytotoxi city of epithelial cells [35] , decreases absorption [36] , increases water flux [37] , increases fluid and electrolyte accumulation [38] , enhances intestinal motility and alters the gastric contractions [39] , representing effects similar to physiopathologic conditions that cause diarrhea in humans. Castor oil produces its laxative effect in association with the release of platelet activating factor, nitric oxide (NO), tachykinins (TKs), cAMP [26, 40] and prostaglandins via EP3 and EP4 receptors' binding [41] . EtOHEMe presented antidiarrheal activity, de creasing the evacuation index at all doses, with crescent percentiles of diarrhea inhibition, along with the standard drug loperamide. These results corroborate a study by Santos et al [6] with Maytenus rigida Mart. ethanolic extract, which was shown to be able to reduce the total number of fecal output and the diarrheic feces for all tested doses. In order to evaluate if EtOHEMe affected gastro intestinal motility, gastric emptying and intestinal transit protocols were performed. The findings suggested an antimotility activity mediated by EtOHEMe, since it was efficient in decreasing gastric emptying and intestinal transit. Similar results were found for a flavonoidrich fraction of Maytenus ilicifolia Reissek, which was able to inhibit the intestinal transit in a more potent way than the gastric emptying [8] . Those results suggested the presence of different mechanisms of action in the different segments of the gastrointestinal system, and likely not liked to gastric dysfunction, since Maytenus species are well known for enhancing the protective effects of the stomach preserving its normal physiology [37] . The control of gastrointestinal motility is very complex and involves multiple signaling pathways, such as NO, gastrin, opioids, 5hydroxytryptamine, dopamine, catecholamines and acetylcholine [42] .
Thus, the mechanistic studies targeting nitrergic and adrenergic pathways were assessed, as well as, the participation of KATP channels involved in the antimotility effect previously evaluated. For that matter, we used drugs with wellknown mechanisms for blocking these pathways, including glibenclamide, a KATP channels blocker, LNAME, an inhibitor of NOs, propranolol, a nonselective adrenergic antagonist, and yohimbine, a presynaptic α2adrenergic antagonist. The results from this experiment suggested the participation of NO and KATP channels, that might involve the NOcGMPKATP pathway, as well as of tissue adrenergic receptors in the antimotility activity, due to the effect reversal when EtOHEMe was administered along with the respective blockers. It is also possible to suggest that this effect does not involve presynaptic α2 adrenergic receptors, since EtOHEMe still decreased intestinal transit in the presence of yohimbine, a blocker of this pathway.
In order to determine if antidiarrheal activity of EtOHEMe was also associated with a reduction in fluid accumulation, the castor oil induced enteropooling model was used. It is possible to suggest through the present results that EtOHE Me ability to reduce diarrhea may also be due to its antisecretory effect and that this mechanism of action might be related to inhibition of secretion, reducing intraluminal fluid accumulation and/or enhancing water and ion absorption. Species such as Psidium guajava and Anacardium occidentale, largely used in traditional medicine as antidiarrheics [24] , have already demonstrated a decrease of fluid accumulation, underlining their antidiarrheal properties [43, 44] . Thus, this work showed, for the very first time, 
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